DUBLIN–(BUSINESS WIRE)–The “Plasma Protein Therapeutics Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering.
The Global Plasma Protein Therapeutics Market is projected to reach USD 49,932.41 million by 2027 from USD 26,361.82 million in 2021, at a CAGR 11.23% during the forecast period.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.
- The Americas Plasma Protein Therapeutics Market size was estimated at USD 9,452.25 million in 2021 and expected to reach USD 10,387.31 million in 2022, at a CAGR 10.82% to reach USD 17,517.43 million by 2027.
- The Asia-Pacific Plasma Protein Therapeutics Market size was estimated at USD 7,540.86 million in 2021 and expected to reach USD 8,483.33 million in 2022, at a CAGR 11.68% to reach USD 14,634.60 million by 2027.
- The Europe, Middle East & Africa Plasma Protein Therapeutics Market size was estimated at USD 9,368.70 million in 2021 and expected to reach USD 10,419.97 million in 2022, at a CAGR 11.26% to reach USD 17,780.37 million by 2027.
Market Segmentation & Coverage:
The report on plasma protein therapeutics identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group’s economies and geographies can help gain business acumen for better strategic decision-making.
The market coverage across different industry verticals reveals the hidden truth about the players’ strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.
This research report categorizes the plasma protein therapeutics to forecast the revenues and analyze the trends in each of the following sub-markets:
Product:
- Albumins
- C1-esterase Inhibitors
- Coagulation Factors
- Hyperimmune Globulins
- Immunoglobulins
Application:
- Hereditary Angioedema
- Idiopathic Thrombocytopenic Purpura
- Primary Immunodeficiency Disorder
- Secondary Immunodeficiency
Region:
-
Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
-
Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
-
Europe, Middle East & Africa
- France
- Germany
- Italy
- Netherlands
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- United Arab Emirates
- United Kingdom
Company Usability Profiles:
- Access Biologicals LLC
- ADMA Biologics, Inc.
- Baxter International Inc.
- Bio Products Laboratory U.S.A., Inc.
- Biotest AG
- Bruker Corporation
- Cara Plasma s.r.o
- China Biologic Products Holdings, Inc.
- CSL Behring
- Grifols, S.A.
- Hemarus Therapeutics Limited
- Kamada Ltd.
- Kedrion S.p.A.
- Laboratory Corporation of America Holdings
- LFB S.A.
- Octapharma AG
- Omega Laboratories Ltd.
- Plasma Protein Therapeutics Association
- Plasma Technologies, LLC
- PlasmaGen BioSciences Pvt. Ltd.
- Reliance Industries Limited
- Scantibodies Laboratory, Inc.
- Takeda Pharmaceutical Company Limited
- Thermo Fisher Scientific, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/q0ytfb
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900